Boswellia frereana (frankincense) suppresses cytokine-induced matrix metalloproteinase expression and production of pro-inflammatory molecules in articular cartilage

Phytotherapy Research

Volumn 24, Issue 6, 2010, Pages 905-912

  Blain, Emma J ^a   Ali, Ahmed Y ^a   Duance, Victor C ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Articular cartilage; Boswellia frereana; Degradation; In vitro model; Inflammation; MMPs

Indexed keywords

ANTIINFLAMMATORY AGENT; BOSWELLIA FREREANA EXTRACT; COLLAGENASE 3; CYCLOOXYGENASE 2; GELATINASE B; INTERLEUKIN 1ALPHA; MESSENGER RNA; NITRIC OXIDE; NITRITE; ONCOSTATIN M; PLANT EXTRACT; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BOSWELLIA; BOSWELLIA FREREANA; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; EXPLANT; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; RNA EXTRACTION; TRANSLATION REGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BOSWELLIA; CARTILAGE, ARTICULAR; CATTLE; CELL SURVIVAL; CHONDROCYTES; CYCLOOXYGENASE 2; DINOPROSTONE; INTERLEUKIN-1ALPHA; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 9; NITRITES; ONCOSTATIN M; OSTEOARTHRITIS; PENTACYCLIC TRITERPENES; PLANT EXTRACTS;

BOSWELLIA FREREANA; BOSWELLIA SACRA;

EID: 77953240717     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3055     Document Type: Article

References (30)

1. Adcocks C, Collin P, Buttle DJ. 2002. Catechins from green tea (Camellia sinensis) inhibit bovine and human cartilage proteoglycan and type II collagen degradation in vitro. J Nutr 132: 341-346. (Pubitemid 34208730)
2. Barksby HE, Hui W, Wappler I, Peters HH, Milner JM, Richards CD, Cawston TE, Rowan AD. 2006. Interleukin-1 in combination with oncostatin M up-regulates multiple genes in chondrocytes: implications for cartilage destruction and repair. Arthritis Rheum 54: 540-550.
3. Berenbaum F. 2008. New horizons and perspectives in the treatment of osteoarthritis. Arthritis Res Ther 10: S1.
4. Blain EJ, Gilbert SJ, Hayes AJ, Duance VC. 2006. Disassembly of the vimentin cytoskeleton disrupts articular cartilage chondrocyte homeostasis. Matrix Biol 25: 398-408.
5. Blain EJ, Gilbert SJ, Wardale RJ, Capper SJ, Mason DJ, Duance VC. 2001. Up-regulation of matrix metalloproteinase expression and activation following cyclical compressive loading of articular cartilage in vitro. Arch Biochem Biophys 396: 49-55.
6. Chowdhury TT, Arghandawi S, Brand J, Akanji OO, Bader DL, Salter DM, Lee DA. 2008. Dynamic compression counteracts IL-1beta induced inducible nitric oxide synthase and cyclooxygenase-2 expression in chondrocyte/agarose constructs. Arthritis Res Ther 10: R35.
7. Davidson RK, Waters JG, Kevorkian L, Darrah C, Cooper A, Donell ST, Clark IM. 2006. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther 8: R124.
8. Ernst E. 2008. Frankincense: systematic review. B M J 337: a2813.
9. Fernandez MA, de las Heras B, Garcia MD, Saenz MT, Villar A. 2001. New insights into the mechanism of action of the anti-inflammatory triterpene lupeol. J Pharm Pharmacol 53: 1533-1539.
10. Fosang AJ, Little CB. 2008. Drug insight: aggrecanases as therapeutic targets for osteoarthritis. Nat Clin Pract Rheumatol 4: 420-427.
11. Frye SR, Yee A, Eskin SG, Guerra R, Cong X, McIntire LV. 2005. cDNA microarray analysis of endothelial cells subjected to cyclic mechanical strain: importance of motion control. Physiol Genomics 21: 124-130.
12. Geetha T, Varalakshmi P. 1999. Effect of lupeol and lupeol linoleate on lysosomal enzymes and collagen in adjuvant-induced arthritis in rats. Mol Cell Biochem 201: 83-87. (Pubitemid 30019368)
13. Kimmatkar N, Thawani V, Hingorani L, Khiyani R. 2003. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee - a randomized double blind placebo controlled trial. Phytomedicine 10: 3-7.
14. Little CB, Flannery CR, Hughes CE, Goodship A, Caterson B. 2005. Cytokine induced metalloproteinase expression and activity does not correlate with focal susceptibility of articular cartilage to degeneration. Osteoarthritis Cartilage 13: 162-170.
15. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
16. Lotz M. 1999. The role of nitric oxide in articular cartilage damage. Rheum Dis Clin North Am 25: 269-282.
17. Milner JM, Rowan AD, Cawston TE, Young DA. 2006. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis. Arthritis Res Ther 8: R142.
18. Morgan TG, Rowan AD, Dickinson SC, Jones D, Hollander AP, Deehan D, Cawston TE. 2006. Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases. Ann Rheum Dis 65: 184-190.
19. Neuman RE, Logan MA. 1950. The determination of hydroxyproline. J Biol Chem 184: 299-306.
20. Pardhy RS, Bhattacharya SC. 1978. Boswellic acid, acetylboswellic acid and 11-keto-boswellic acid, four pentacyclic triterpenic acids from the resin of Boswellia serrata. Indian Journal of Chemistry 16B: 176-178.
21. Pelletier JP, Lascau-Coman V, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, Martel-Pelletier J. 1999. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol 26: 2002-2014. (Pubitemid 30007071)
22. Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP. 1992. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 261: 1143-1146.
23. Schulze-Tanzil G, Mobasheri A, Sendzik J, John T, Shakibaei M. 2004. Effects of curcumin (diferuloylmethane) on nuclear factor kappaB signaling in interleukin-1beta-stimulated chondrocytes. Ann N Y Acad Sci 1030: 578-586.
24. Sengupta K, Alluri KV, Satish AR, Mishra S, Golakoti T, Sarma KV, Dey D, Raychaudhuri SP. 2008. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther 10: R85.
25. Shakibaei M, Csaki C, Nebrich S, Mobasheri A. 2008. Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol 76: 1426-1439.
26. Siemoneit U, Hofmann B, Kather N, Lamkemeyer T, Madlung J, Franke L, Schneider G, Jauch J, Poeckel D, Werz O. 2008. Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids. Biochem Pharmacol 75: 503-513.
27. Singh S, Khajuria A, Taneja SC, Johri RK, Singh J, Qazi GN. 2008. Boswellic acids: A leukotriene inhibitor also effective through topical application in inflammatory disorders. Phytomedicine 15: 400-407.
28. Sontakke S, Thawani V, Pimpalkhute P, Kabra P, Babhulkar S, Hingorani H. 2007. Open, randomised, controlled clinical trial of Boswellia serrata extract as compared to valdercoxib in osteoarthritis of knee. Indian Journal of Pharmacology 39: 27-29. (Pubitemid 46381930)
29. Struglics A, Larsson S, Pratta MA, Kumar S, Lark MW, Lohmander LS. 2006. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarthritis Cartilage 14: 101-113.
30. Zhao W, Entschladen F, Liu H, Niggemann B, Fang Q, Zaenker KS, Han R. 2003. Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells. Cancer Detect Prev 27: 67-75.